False Claims Act Liability for Overtreatment

2020 ◽  
Vol 45 (3) ◽  
pp. 419-437 ◽  
Author(s):  
David Howard

Abstract Context: Overtreatment is costly, but is it fraud? In a growing number of False Claims Act cases, the Department of Justice has sought and received multimillion dollar settlements from providers accused of billing Medicare for unnecessary care. This article evaluates the use of the False Claims Act as a tool for reducing overuse. Methods: The author reviewed (1) recent cases where litigants sparred over the applicability of the False Claims Act to overtreatment, and (2) criticisms of the expanding use of the False Claims Act in health care. Findings: Some judges have dismissed suits on the grounds that expert testimony regarding the necessity of treatment is insufficient for concluding Medicare claims were false or fraudulent. Other judges have let cases proceed, especially in instances where clinicians appear to have overstated the severity of patients' illnesses to justify treatment. Cases that lead to changes in medical practice may result in substantial savings to the Medicare program. Conclusions: Courts have struggled with how to apply the False Claims Act to overtreatment. False Claims Act cases that address unnecessary care are potentially less problematic than other types of cases that address technical violations with few implications for costs or quality.

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 4275-4275
Author(s):  
Zhiqiang Lu ◽  
Zaina Parvez Qureshi ◽  
Brian Chen ◽  
Sudha Xirasagar ◽  
Paul Ray ◽  
...  

Abstract Abstract 4275 Introduction: Annually, $82 billion to $272 billion is reportedly lost to federal health care fraud. Between 1996 and 2005, 379 federal health care fraud cases initiated by qui tam relators (“whistle blowers”) concluded, resulting in $9.3 billion in recoveries. Of these, pharmaceutical companies accounted for 13 cases (False Claims Act (FCA) cases, the primary statute invoked in health care fraud and abuse), but $3.9 billion of recoveries (4% of the cases and 39% of the financial recoveries). We report concluded FCA cases involving pharmaceutical manufacturers between 2006 and 2011. Oncology accounts for the largest per cent of total pharmaceutical expenditures. Over 90% of all new cancer pharmaceuticals cost > $20,000 for 12-weeks of treatment. Methods: Websites for the Department of Justice (DOJ), Taxpayers Against Fraud, Health and Human Services Inspector General's Office, Health Care Fraud and Abuse Control Project, and Lexis/Nexis were queried for pharmaceutical FCA cases (2006 to 2011). Results: Between 2006 and 2011, the DOJ closed 54 cases with pharmaceutical FCA violations, 38 with and 16 without qui tam relators, accounting for recoveries of $11.3 billion (mean $296 million) and $2.6 billion (mean, $165 million), respectively. Illegal marketing is the most common fraud allegations invoked against pharmaceutical manufacturers (19 cases). Pharmaceutical manufacturers accounted for 31% of total FCA cases, and 71.5% of total FCA recoveries (Table 1). Conclusion: Since the DOJ's shift of focus to pharmaceutical corporations in 2001, the trend has intensified, with virtually every large pharmaceutical corporation settling at least one FCA case. Pharmaceutical cases now account for 31% of the federal fraud cases and 71% of the financial recoveries. Fraud and abuse may be an important component of the high costs of cancer care in the United States. Moreover, unless fundamental changes occur, the pharmaceutical industry will continue to be the main FCA investigative target as this sector has the deepest pockets and is the health care sector most resistant to deterrence. Disclosures: No relevant conflicts of interest to declare.


Author(s):  
Mohammed Shanshal ◽  
Hayder Saad Ahmed ◽  
Hayder Asfoor ◽  
Raad Ibrahim Salih ◽  
Shehab Ahmed Ali ◽  
...  

2000 ◽  
Vol 26 (2-3) ◽  
pp. 175-186
Author(s):  
Timothy S. Jost

If any trend can be confidently predicted for the next millennium (or, more modestly, for our lifetimes) it is the globalization of health law. We live in an age of global markets and global communications. While care of the individual patient has remained largely local, national borders are quite porous to health care professionals. The cross-border flow of patients is a significant factor in some regions, and the development of telemedicine and internet pharmacies is radically expanding the possibility of cross-border medical practice.


2015 ◽  
Author(s):  
Elizabeth G Nabel

The role of a physician as healer has grown more complex, and emphasis will increasingly be on patient and family-centric care. Physicians must provide compassionate, appropriate, and effective patient care by demonstrating competence in the attributes that are essential to successful medical practice. Beyond simply gaining medical knowledge, modern physicians embrace lifelong learning and need effective interpersonal and communication skills. Medical professionalism encompasses multiple attributes, and physicians are increasingly becoming part of a larger health care team. To ensure that physicians are trained in an environment that fosters innovation and alleviates administrative burdens, the Accreditation Council for Graduate Medical Education has recently revamped the standards of accreditation for today’s more than 130 specialties and subspecialties. This chapter contains 6 references and 5 MCQs.


Signs ◽  
1989 ◽  
Vol 14 (2) ◽  
pp. 434-473 ◽  
Author(s):  
Monica Green

Author(s):  
Lyudmila Ilyinichna Kaspruk

The results of the historical and medical analysis of the processes of formation and development of primary care in the Orenburg Region are quite relevant, especially in connection with the renewed demand for resolving urgent issues that have arisen in the system of domestic health care. Consideration of the above aspects on the example of a separate territory, the Orenburg Region, is significant, given that public health care is formed by various structures of territorial systems in the context of demographic, social and economic gradations.


PEDIATRICS ◽  
1981 ◽  
Vol 68 (4) ◽  
pp. 578-578
Author(s):  
A. D. Roberts

What are we offered today by the aggressive new breed of leaders and educators in nursing? An angry, dwindling profession, failing with increasing frequency to meet the needs of patients and physicians and in the process making themselves and everyone else miserable. The idealistic young people who come into the profession to actually nurse patients are sometimes made to feel like Aunt Jemiinas, become discouraged and leave, or, if they remain, are denied status, promotions and raises. The "new model" nursing leaders and educators pursue higher status, higher incomes, more respect and recognition—as indeed most of us do. There's nothing wrong with that. What is damaging is the mode of attack. By striving to capture some independent middle ground between classical nursing and medical practice, nursing leaders threaten to make of their professionals neither nurses nor physicians, fit only to cause trouble: trouble for people who really want to nurse, trouble for physicians and administrators who can't get the help they need and, most of all, trouble for patients, who often cannot get timely medicines and competent ministrations without hiring a private-duty nurse. And even then competence is far from assured. Many nursing leaders and educators seem intent on abandoning a badly needed profession in the search for a new category of health-care professional that no one has asked for and hardly anyone needs. They have not merely neglected and downgraded classical, basic nursing; they have also sought to restrict entry into the profession by raising the standards of accreditation of schools of nursing and of licensure of individuals in many instances beyond what is necessary for the basic skills that are in such short supply.


Sign in / Sign up

Export Citation Format

Share Document